United States · FDA National Drug Code directory
Letrozole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 17856-0032_38546ba0-8feb-9cf6-e063-6294a90a074c
- Product NDC
- 17856-0032
- Form
- TABLET, FILM COATED
- Composition / generic term
- letrozole
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200113
- Source listing expiry
- 20261231
Source-listed ingredients
- LETROZOLE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 POUCH in 1 BOX, UNIT-DOSE (17856-0032-1) / 1 TABLET, FILM COATED in 1 POUCH · 17856-0032-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →